Offerings // Citius Pharmaceuticals, Inc.

CTXR offering history

Every offering-related filing in Citius Pharmaceuticals, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 630 filings back to Nov 23, 2010.

Last executed offering

Apr 29, 2026

8-K — priced deal (shares or notes)

Last registration (announced)

May 22, 2026

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Jun 2, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 22, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Apr 29, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Apr 24, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 21, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 11, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 18, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Apr 2, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 8, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 18, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 12, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 26, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 1, 2024	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Feb 23, 2024	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
May 5, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 23, 2021	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Jul 8, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 20, 2021	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 20, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 13, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Apr 16, 2021	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 16, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Apr 2, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Apr 1, 2021	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Mar 26, 2021	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Feb 19, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Feb 18, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 16, 2021	S-3MEF →	REGISTERED	S-3MEF registration — capacity to sell shares, not a sale yet
Feb 5, 2021	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Feb 5, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 29, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jan 27, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Sep 30, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 25, 2020	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Sep 25, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 11, 2020	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Aug 7, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 6, 2020	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Aug 5, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 5, 2020	FWP →	MARKETING	Free-writing prospectus — offering being marketed

CTXR offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full CTXR workspace →

CTXR offering FAQ

When did CTXR last execute an offering?

Per SEC filings, Citius Pharmaceuticals, Inc.'s most recent priced offering document is a 8-K filed 2026-04-29. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did CTXR last announce or register an offering?

The most recent registration is a S-3 filed 2026-05-22. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.